PT - JOURNAL ARTICLE AU - Suputtitada, Areerat AU - Chen, Carl PC AU - Ngamrungsiri, Narin AU - Schmitz, Christoph TI - Effects of Radial Extracorporeal Shockwave Therapy Versus 1% Lidocaine Injection for Myofascial Trigger Points Measured with Elastic Index AID - 10.1101/2021.04.04.21254889 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.04.21254889 4099 - http://medrxiv.org/content/early/2021/04/09/2021.04.04.21254889.short 4100 - http://medrxiv.org/content/early/2021/04/09/2021.04.04.21254889.full AB - Purpose To compare the efficacy of radial extracorporeal shockwave therapy (rESWT) versus injection of 1% lidocaine for active myofascial trigger points (MTPs) at upper trapezius muscle (UTM) objectively with elastic index analysis.Patients and methods A prospective, randomised, single-blinded clinical trial was done. 60 patients with active MTPs of UTM were randomised to receive either rESWT (n = 30); three rESWT sessions; one session per week; 2000 rESWT impulses per session; positive energy flux density = 0.10 mJ/mm2) or 1% lidocaine (4 ml) injection (n = 30) (three injections; one injection per week). The outcome measure was the elastic index of MTPs, visual analogue score (VAS score) of pain, and pressure pain threshold (PPT) three weeks after baseline.Results Both rESWT and injection of 1% lidocaine resulted in statistically significant (P < 0.05) reduced elastic index and VAS of pain of UTM and PPT significantly (P < 0.05) at three weeks after baseline. The mean differences between rESWT and injection of 1%lidocaine showed no statistically siginificance.Conclusion Both rESWT and 1% lidocaine injection had efficacy for active MTPs of UTM measured with elastic index, VAS of pain and PPT.HighlightsExtracorporeal shockwave therapy (ESWT) is an alternative to 1%lidocaine injection for myofascial trigger points (MTPs).Elastic index provides evidence for the quantitative assessment of MTPs.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialTCTR20160330003Funding StatementThis study received a grant from Ratchadapiseksomphot Endowment Fund, Faculty of Medicine, Chulalongkorn University,Bangkok.Thailand.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Protocol No.: 222/57; date of approval by the ethics committee: September 17, 2015) before starting the study, and was carried out in accordance with the World Medical Association (WMA) Declaration of HelsinkiAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthe availability of all data at department of Rehabilitation Medicine,Faculty of Medicine, Chulalongkorn University,Bangkok,ThailandMTPmyofascial trigger pointMPSmyofascial pain syndromerESWTradial shock wave therapyUTMupper trapezius musclesEIelastic indexVASvisual analog scalePPTpressure pain thresholdNDIneck disability index